Oligonucleotide (ON) drug development is accelerating rapidly—but first‑in‑human (FIH) studies remain complex. Listen to our recent webinar where specialists discussed: - Translational PK/PD and toxicity considerations ...
- Home
- News & Events
- Events
- Webinars
Webinars
-
Webinars
Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk
Date 5 November 2026 Time 11:00 - 12:00 Location Webinar Timezone EDT - America/New York -
Webinars
Obesity studies: The enrolment vs. retention balancing act
Date 14 October 2026 Time 15:00 - 16:00 Location Webinar Timezone BST - Europe/Dublin -
Webinars
Strategic approaches for early clinical trials in neurodegenerative diseases
Date 14 October 2026 Time 15:00 - 16:00 Location Webinar Timezone CET - Europe/Madrid -
Webinars
Meeting Sites Where They Are: A Connected, Intelligence-Powered Operating Model
Date 28 July 2026 Time 10:00 - 11:00 Location Webinar Timezone EST - America/New York -
Webinars
Insights into first-in-human study design of oligonucleotides
Date 27 May 2026 Time 15:00 - 16:00 Location Webinar Timezone BST - Europe/Dublin -
Webinars
Panel discussion: Flow cytometry in bioanalysis
Date 26 March 2026 Time 11:00 - 12:00 Location Webinar Timezone America/New York -
Webinars
Best practices in global flow cytometry quality control and harmonisation
Date 5 March 2026 Time 15:00 - 15:30 Location Webinar Timezone GMT - Europe/London -
Webinars
When patients lead: Breaking barriers in ultra-rare disease drug development
Date 3 March 2026 Time 11:00 - 12:00 Location Webinar Timezone EST - America/New York -
Webinars
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Date 16 December 2025 Time 09:30 - 10:30 Location Webinar Timezone EST - America/New York
ICON’s Webinar Channel
A library of recorded webinars exploring topics ranging from early to late phase.